Remarkably, they were not capable of presenting the patient-specific tumor idiotype to autologous T cells.
DCs generated in vitro from CD14 (+) monocytes from the same patients, and PBDCs freshly isolated from healthy donors efficiently stimulated allogeneic and autologous T cells.